|
1
|
Robin PD, Powell DJ and Stansbie JM:
Carcinoma of the nasal cavity and paranasal sinuses: Incidence and
presentation of different histological types. Clin Otolaryngol
Allied Sci. 4:431–456. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Batsakis JG, Rice DH and Solomon AR: The
pathology of head and neck tumors: Squamous and mucous-gland
carcinomas of the nasal cavity, paranasal sinuses, and larynx, part
6. Head Neck Surg. 2:497–508. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Weber AL and Stanton AC: Malignant tumors
of the paranasal sinuses: Radiologic, clinical, and histopathologic
evaluation of 200 cases. Head Neck Surg. 6:761–776. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lopez JI, Nevado M, Eizaguirre B and Perez
A: Intestinal-type adenocarcinoma of the nasal cavity and paranasal
sinuses. A clinicopathologic study of 6 cases. Tumori. 76:250–254.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kleinsasser O and Schroeder HG:
Adenocarcinomas of the inner nose after exposure to wood dust.
Morphological findings and relationships between histopathology and
clinical behavior in 79 cases. Arch Otorhinolaryngol. 245:1–15.
1988. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Leclerc A, Cortes MM, Gerin M, Luce D and
Brugere J: Sinonasal cancer and wood dust exposure: Results from a
case-control study. Am J Epidemiol. 140:340–349. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stellman SD, Demers PA, Colin D and
Boffetta P: Cancer mortality and wood dust exposure among
participants in the American cancer society cancer prevention
study-II (CPS-II). Am J Ind Med. 34:229–237. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hadfield EH: A study of adenocarcinoma of
the paranasal sinuses in woodworkers in the furniture industry. Ann
R Coll Surg Engl. 46:301–319. 1970.PubMed/NCBI
|
|
9
|
Klintenberg C, Olofsson J, Hellquist H and
Sökjer H: Adenocarcinoma of the ethmoid sinuses. A review of 28
cases with special reference to wood dust exposure. Cancer.
54:482–488. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Barnes L: Intestinal-type adenocarcinoma
of the nasal cavity and paranasal sinuses. Am J Surg Pathol.
10:192–202. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Franchi A, Gallo O and Santucci M:
Clinical relevance of the histological classification of sinonasal
intestinal-type adenocarcinomas. Hum Pathol. 30:1140–1145. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fiaux-Camous D, Chevret S, Oker N,
Turri-Zanoni M, Lombardi D, Choussy O, Frederic D, Jorissen M, de
Gabory L, Malard O, et al: Prognostic value of the seventh
AJCC/UICC TNM classification of intestinal-type ethmoid
adenocarcinoma: Systematic review and risk prediction model. Head
Neck. 39:668–678. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Maccariello G, Deganello A, Choussy O,
Gallo O, Vitali D, De Raucourt D and Georgalas C: Endoscopic nasal
versus open approach for the management of sinonasal
adenocarcinoma: A pooled-analysis of 1826 patients. Head Neck. 38
(Suppl 1):E2267–E2274. 2016.PubMed/NCBI
|
|
14
|
Mills SE, Fechner RE and Cantrell RW:
Aggressive sinonasal lesion resembling normal intestinal mucosa. Am
J Surg Pathol. 6:803–809. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Batsakis JG, Mackay B and Ordonez NG:
Enteric-type adenocarcinoma of the nasal cavity. An electron
microscopic and immunocytochemical study. Cancer. 54:855–860. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
McKinney CD, Mills SE and Franquemont DW:
Sinonasal intestinal-type adenocarcinoma: Immunohistochemical
profile and comparison with colonic adenocarcinoma. Mod Pathol.
8:421–426. 1995.PubMed/NCBI
|
|
17
|
Franchi A, Massi D, Baroni G and Santucci
M: CDX-2 homeobox gene expression. Am J Surg Pathol. 27:1390–1391.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Saber AT, Nielsen LR, Dictor M, Hagmar L,
Mikoczy Z and Wallin H: K-ras mutations in sinonasal
adenocarcinomas in patients occupationally exposed to wood or
leather dust. Cancer Lett. 126:59–65. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Perez P, Dominguez O, Gonzalez S, Trivino
A and Suarez C: Ras gene mutations in ethmoid sinus adenocarcinoma:
Prognostic implications. Cancer. 86:255–264. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu TT, Barnes L, Bakker A, Swalsky PA and
Finkelstein SD: K-ras-2 and p53 genotyping of intestinal-type
adenocarcinoma of the nasal cavity and paranasal sinuses. Mod
Pathol. 9:199–204. 1996.PubMed/NCBI
|
|
21
|
Perrone F, Oggionni M, Birindelli S,
Suardi S, Tabano S, Romano R, Moiraghi ML, Bimbi G, Quattrone P,
Cantu G, et al: TP53, p14ARF, p16INK4a and H-ras gene molecular
analysis in intestinal-type adenocarcinoma of the nasal cavity and
paranasal sinuses. Int J Cancer. 105:196–203. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Re M, Magliulo G, Tarchini P, Mallardi V,
Rubini C, Santarelli A and Lo Muzio L: p53 and BCL-2
over-expression inversely correlates with histological
differentiation in occupational ethmoidal intestinal-type sinonasal
adenocarcinoma. Int J Immunopathol Pharmacol. 24:603–609. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gallo O, Franchi A, Fini-Storchi I,
Cilento G, Boddi V, Boccuzzi S and Urso C: Prognostic significance
of c-erbB-2 oncoprotein expression in intestinal-type
adenocarcinoma of the sinonasal tract. Head Neck. 20:224–231. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Re M, Santarelli A, Mascitti M, Bambini F,
Lo Muzio L, Zizzi A and Rubini C: Trail overexpression inversely
correlates with histological differentation in intestinal-type
sinonasal adenocarcinoma. Int J Surg Oncol.
2013:2038732013.PubMed/NCBI
|
|
25
|
Tomassetti M, Re M, Monaco F, Gaetani S,
Rubini C, Bertini A, Pasquini E, Bersaglieri C, Bracci M,
Staffolani S, et al: MiR-126 in intestinal-type sinonasal
adenocarcinomas: Exosomal transfer of MiR-126 promotes anti-tumour
responses. BMC Cancer. 18:8962018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Re M, Magliulo G, Ferrante L, Zizzi A,
Santarelli A, Stramazzotti D, Lo Muzio L, Goteri G and Rubini C:
p63 expression in laryngeal squamous cell carcinoma is related to
tumor extension, histologic grade, lymph node involvement and
clinical stage. J Biol Regul Homeost Agents. 27:121–129.
2013.PubMed/NCBI
|
|
27
|
Re M, Zizzi A, Ferrante L, Stramazzotti D,
Goteri G, Gioacchini FM, Olivieri F, Magliulo G and Rubini C: p63
and Ki-67 immunostainings in laryngeal squamous cell carcinoma are
related to survival. Eur Arch Otorhinolaryngol. 271:1641–1651.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Re M, Ceka A, Rubini C, Ferrante L, Zizzi
A, Gioacchini FM, Tulli M, Spazzafumo L, Sellari-Franceschini S,
Procopio AD and Olivieri F: MiR-34c-5p is related to recurrence in
squamous cell carcinoma. Laryngoscope. 125:E306–E312. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lucarini G, Zizzi A, Re M, Sayeed MA, Di
Primio R and Rubini C: Prognostic implication of CEACAM1 expression
in squamous cell carcinoma of the larynx: Pilot study. Head Neck.
41:1615–1621. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Re M, Gioacchini FM, Scarpa A, Cassandro
C, Tulli M and Cassandro E: The prognostic significance of
E-cadherin expression in laryngeal squamous cell carcinoma: A
systematic review. Acta Otorhinolaryngologica Ital. 38:504–510.
2018. View Article : Google Scholar
|
|
31
|
Re M, Magliulo G, Gioacchini FM,
Bajraktari A, Bertini A, Ceka A, Rubini C, Ferrante L, Procopio AD
and Olivieri F: Expression levels and clinical significance of
miR-21-5p, miR-let-7a, and miR-34c-5p in laryngeal squamous cell
carcinoma. Biomed Res Int. 2017:39212582017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Re M, Gioacchini FM, Bajraktari A,
Tomassetti M, Kaleci S, Rubini C, Bertini A, Magliulo G and
Pasquini E: Malignant transformation of sinonasal inverted
papilloma and related genetic alterations: A systematic review. Eur
Arch Otorhinolaryngol. 274:2991–3000. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gioacchini FM, Alicandri-Ciufelli M,
Rubini C, Magliluo G and Re M: Prognostic value of Bcl-2 expression
in squamous cell carcinoma of the larynx: A systematic review. Int
J Biol Markers. 30:e155–e160. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gioacchini FM, Alicandri-Ciufelli M,
Kaleci S, Magliulo G, Presutti L and Re M: The prognostic value of
Cyclin D1 expression in head and neck sqamous cell carcinoma. Eur
Arch Otorhinolaryngol. 273:801–809. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gioacchini FM, Alicandri-Ciufelli M,
Magliulo G, Rubini C, Presutti L and Re M: The clinical relevance
of Ki-67 expression in laryngeal squamous cell carcinoma. Eur Arch
Otorhinolaryngol. 272:1569–1576. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Re M, Magliulo G, Salvolini E, Orciani M,
Gioacchini FM, Goteri G and Rubini C: Prognostic significance of
p53 and KAI-1 expression in patients with Laryngeal squamous cell
carcinoma. Anal Quant Cytol Histol. 32:247–253. 2010.PubMed/NCBI
|
|
37
|
Fan CY: Epigenetic alterations in head and
neck cancer: Prevalence, clinical significance, and implications.
Curr Oncol Rep. 6:152–161. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Marsit CJ, Christensen BC, Houseman EA,
Karagas MR, Wrensch MR, Yeh RF, Nelson HH, Wiemels JL, Zheng S,
Posner MR, et al: Epigenetic profiling reveals etiologically
distinct patterns of DNA methylation in head and neck squamous cell
carcinoma. Carcinogenesis. 30:416–422. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Worsham MJ, Chen KM, Meduri V, Nygren AO,
Errami A, Schouten JP and Benninger MS: Epigenetic events of
disease progression in head and neck squamous cell carcinoma. Arch
Otolaryngol Head Neck Surg. 132:668–677. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zamore PD and Haley B: Ribo-gnome: The big
world of small RNAs. Science. 309:1519–1524. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Schickel R, Boyerinas B, Park SM and Peter
ME: MicroRNAs: Key players in the immune system, differentiation,
tumorigenesis and cell death. Oncogene. 27:5959–5974. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cullen BR: Transcription and processing of
human microRNA precursors. Mol Cell. 16:861–865. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Avissar M, McClean MD, Kelsey KT and
Marsit CJ: MicroRNA expression in head and neck cancer associates
with alcohol consumption and survival. Carcinogenesis.
30:2059–2063. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chen CZ: MicroRNAs as oncogenes and tumor
suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Iorio MV, Ferracin M, Liu CG, Veronese A,
Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M,
et al: MicroRNA gene expression deregulation in human breast
cancer. Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Calin GA, Ferracin M, Cimmino A, Di Leva
G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, et
al: A MicroRNA signature associated with prognosis and progression
in chronic lymphocytic leukemia. N Engl J Med. 353:1793–1801. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yan LX, Huang XF, Shao Q, Huang MY, Deng
L, Wu QL, Zeng YX and Shao JY: MicroRNA miR-21 overexpression in
human breast cancer is associated with advanced clinical stage,
lymph node metastasis and patient poor prognosis. RNA.
14:2348–2360. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Schetter AJ, Leung SY, Sohn JJ, Zanetti
KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, et
al: MicroRNA expression profiles associated with prognosis and
therapeutic outcome in colon adenocarcinoma. JAMA. 299:425–436.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chen Y and Stallings RL: Differential
patterns of microRNA expression in neuroblastoma are correlated
with prognosis, differentiation, and apoptosis. Cancer Res.
67:976–983. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Avissar M, Christensen BC, Kelsey KT and
Marsit CJ: MicroRNA expression ratio is predictive of head and neck
squamous cell carcinoma. Clin Cancer Res. 15:2850–2855. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Chang SS, Jiang WW, Smith I, Poeta LM,
Begum S, Glazer C, Shan S, Westra W, Sidransky D and Califano JA:
MicroRNA alterations in head and neck squamous cell carcinoma. Int
J Cancer. 123:2791–2797. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Childs G, Fazzari M, Kung G, Kawachi N,
Brandwein-Gensler M, McLemore M, Chen Q, Burk RD, Smith RV,
Prystowsky MB, et al: Low-level expression of microRNAs let-7d and
miR-205 are prognostic markers of head and neck squamous cell
carcinoma. Am J Pathol. 174:736–745. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ramdas L, Giri U, Ashorn CL, Coombes KR,
El-Naggar A, Ang KK and Story MD: miRNA expression profiles in head
and neck squamous cell carcinoma and adjacent normal tissue. Head
Neck. 31:642–654. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Long XB, Sun GB, Hu S, Liang GT, Wang N,
Zhang XH, Cao PP, Zhen HT, Cui YH and Liu Z: Let-7a microRNA
functions as a potential tumor suppressor in human laryngeal
cancer. Oncol Rep. 22:1189–1195. 2009.PubMed/NCBI
|
|
56
|
Cardesa A, Gale N, Nadal A and Zidar N:
Squamus cell carcinoma. Head and Neck tumors: Pathology &
Genetics. World Health Organization Classification on Tumors (WHO);
2005, pp. 118–119
|
|
57
|
Edge SB and Compton CC: The American joint
committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Rampelli V, Ferrari M and Nicolai P:
Intestnal-type adenocarcinoma of the sinonasal tract: An update.
Curr Opin Otolaryngol Head Neck Surg. 26:115–121. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Nicolai P, Shreiber A, Villaret AB,
Lombardi D, Morassi L, Raffetti E, Donato F, Battaglia P,
Turri-Zanoni M, Bignami M and Castelnuovo P: Intestinal type
adenocarcinoma of the ethmoid: Outcomes of a treatment regimen
based on endoscopic surgery with or without radiotherapy. Head
Neck. 38:E996–E1003. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Fearon ER and Vogelstein B: A genetic
model for colorectal tumorigenesis. Cell. 61:759–767. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Chung DC: The genetic basis of colorectal
cancer: Insights into critical pathways of tumorigenesis.
Gastroenterology. 119:854–865. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Calvert PM and Frucht H: The genetics of
colorectal cancer. Ann Intern Med. 137:603–612. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Licitra L, Suardi S, Bossi P, Locati LD,
Mariani L, Quattrone P, Lo Vullo S, Oggionni M, Olmi P, Cantu G, et
al: Prediction of TP53 status for primary cisplatin, fluorouracil,
and leucovorin chemotherapy in ethmoid sinus intestinal-type
adenocarcinoma. J Clin Oncol. 22:4901–4906. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Perez-Ordonez B, Huynh NN, Berean KW and
Jordan RC: Expression of mismatch repair proteins, beta catenin,
and E cadherin in intestinal-type sinonasal adenocarcinoma. J Clin
Pathol. 57:1080–1083. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Kennedy MT, Jordan RC, Berean KW and
Perez-Ordonez B: Expression pattern of CK7, CK20, CDX-2, and villin
in intestinal-type sinonasal adenocarcinoma. J Clin Pathol.
57:932–937. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Tu HF, Lin SC and Chang KW: MicroRNA
aberrances in head and neck cancer: Pathogenetic and clinical
significance. Curr Opin Otolaryngol Head Neck Surg. 21:104–111.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Lee YS and Dutta A: MicroRNAs: Small but
potent oncogenes or tumor suppressors. Curr Opin Investig Drugs.
7:560–564. 2006.PubMed/NCBI
|
|
70
|
Price C and Chen J: MicroRNAs in cancer
biology and therapy: Current status and perspectives. Genes Dis.
1:53–63. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Takamizawa J, Konishi H, Yanagisawa K,
Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y,
et al: Reduced expression of the let-7 microTNAs in human lung
cancer in association with shortened postoperative survival. Cancer
Res. 64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
He X, Duan C, Chen J, Ou-Yang X, Zhang Z,
Li C and Peng H: Let-7a elevates p21(WAF1) levels by targeting of
NIRF and suppresses the growth of A549 lung cancer cells. FEBS
Lett. 583:3501–3507. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Akao Y, Nakagawa Y and Naoe T: Let-7
microRNA functions as a potential growth suppressor in human colon
cancer cell. Biol Pharm Bull. 29:903–906. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Colamaio M, Calì G, Sarnataro D, Borbone
E, Pallante P, Decaussin-Petrucci M, Nitsch L, Croce CM, Battista S
and Fusco A: Let-7a down-regulation plays a role in thyroid
neoplasias of follicular histotype affecting cell adhesion and
migration through its ability to target the FXYD5 (Dysadherin)
gene. J Clin Endocrinol Matab. 97:E2168–E2178. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Liu Y, Yin B, Zhang C, Zhou L and Fan J:
Hsa-let-7a functionsas a tumor suppressor in renal cell carcinoma
cell lines by targetingc-myc. Biochem Biophys Res Commun.
417:371–375. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Yang Q, Jie Z, Cao H, Greenlee AR, Yang C,
Zou F and Jiang Y: Low-level expression of let-7a in gastric cancer
and its involvement in tumorigenesis by targeting RAB40C.
Carcinogenesis. 32:713–722. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
De Vito C, Riggi N, Suvà ML, Janiszewska
M, Horlbeck J, Baumer K, Provero P and Stamenkovic I: Let-7a is a
direct EWS-FLI-1 target implicated in Ewing's sarcoma development.
PLoS One. 6:e235922011. View Article : Google Scholar : PubMed/NCBI
|
